GlassScriptPhysician profile
Michael Sumner Gurney
NPI 1235134321
$9,093.48
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,656 · 2020: $1,986 · 2021: $3,257 · 2022: $2,194.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,122.40 | 2019-2022 | |
| Abbvie INC. | $1,702.63 | 2019-2022 | |
| Janssen Biotech, INC. | $1,156.40 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $616.27 | 2019-2022 | |
| Daiichi Sankyo INC. | $542.62 | 2019-2022 | |
| Celgene Corporation | $357.75 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $317.14 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $285.14 | 2019-2022 | |
| Qol Medical, LLC | $266.21 | 2019-2022 | |
| Redhill Biopharma INC. | $247.02 | 2020-2022 | |
| Pfizer INC. | $167.57 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $165.54 | 2020-2022 | |
| Ucb, INC. | $158.53 | 2019-2021 | |
| Ardelyx, INC. | $137.37 | 2022 | |
| Ironwood Pharmaceuticals, INC | $121.97 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $115.33 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $111.39 | 2019-2022 | |
| Evoke Pharma, INC. | $104.40 | 2020-2022 | |
| Vivus LLC | $77.80 | 2019-2022 | |
| Braintree Laboratories, INC. | $63.52 | 2021-2022 | |
| Alfasigma USA, INC. | $52.62 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $43.40 | 2022 | |
| Genzyme Corporation | $37.18 | 2022 | |
| Amgen INC. | $32.71 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $23.96 | 2022 | |
| Axonics, INC. | $20.98 | 2021 | |
| Albireo Pharma, INC. | $16.89 | 2022 | |
| Organon LLC | $14.66 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.08 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gurney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.